The cirrhosis incidence and exacerbation rate in the treated group were 35.00 % ( 7/20 ) and 50.00 % ( 20/40 ) respectively , while in the control group , they were 65.00 % ( 13/20 ) and 76.67 % ( 23/30 ) respectively .
